Home The Word Brain	My Amedeo FAQ Privacy About
	As of September 2023, Amedeo had 10,218 active subscribers with known affiliations

Stroke

Free Subscription Articles published in Circulation Retrieve available abstracts of 139 articles: HTML format

Single Articles

October 2023
1. SMOLDEREN KG, Samaan Z, Decker C, Collins T, et al
   Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association.
   Circulation. 2023 Oct 2. doi: 10.1161/CIR.0000000000001178.
   PubMed     Abstract available
   
   
   September 2023
2. CONNOLLY SJ, Healey JS, Belley-Cote EP, Balasubramanian K, et al
   Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III.
   Circulation. 2023 Sep 21. doi: 10.1161/CIRCULATIONAHA.122.060315.
   PubMed     Abstract available
   
   
   
3. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
   Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
   Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
   PubMed     Abstract available
   
   
   August 2023
4. VINDING NE, Butt JH, Lauridsen MD, Kristensen SL, et al
   Long-term Incidence of Ischemic Stroke Following Transient Ischemic Attack: A Nationwide Study During 2014-2020.
   Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.065446.
   PubMed     Abstract available
   
   
   
5. ZIMMERMANN FM, Ding VY, Pijls NHJ, Piroth Z, et al
   Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
   Circulation. 2023 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.065770.
   PubMed     Abstract available
   
   
   
6. SARMA S, Levine BD
   Response by Sarma and Levine to Letters Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
   Circulation. 2023;148:620-621.
   PubMed    
   
   
   
7. WUSSLER D, Belkin M, Mueller C
   Letter by Wussler et al Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
   Circulation. 2023;148:619.
   PubMed    
   
   
   
8. DIMOPOULOS S, Nanas S
   Letter by Dimopoulos and Nanas Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
   Circulation. 2023;148:617-618.
   PubMed    
   
   
   
9. DENNISON HIMMELFARB CR, Beckie TM, Allen LA, Commodore-Mensah Y, et al
   Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association.
   Circulation. 2023 Aug 14. doi: 10.1161/CIR.0000000000001162.
   PubMed     Abstract available
   
   
   
10. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Response by Zeitler et al to Letter Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:510-511.
    PubMed    
    
    
    
11. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    PubMed    
    
    
    July 2023
12. VIRANI SS, Newby LK, Arnold SV, Bittner V, et al
    2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023 Jul 20. doi: 10.1161/CIR.0000000000001168.
    PubMed     Abstract available
    
    
    
13. VAN DE WERF F, Ristic AD, Averkov OV, AriasMendoza A, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial.
    Circulation. 2023 Jul 13. doi: 10.1161/CIRCULATIONAHA.123.064521.
    PubMed     Abstract available
    
    
    June 2023
14. CAPODANNO D, Mehran R, Krucoff MW, Baber U, et al
    Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
    Circulation. 2023;147:1933-1944.
    PubMed     Abstract available
    
    
    
15. GOLBUS JR, Lopez-Jimenez F, Barac A, Cornwell WK 3rd, et al
    Digital Technologies in Cardiac Rehabilitation: A Science Advisory From the American Heart Association.
    Circulation. 2023 Jun 5. doi: 10.1161/CIR.0000000000001150.
    PubMed     Abstract available
    
    
    May 2023
16. MAN S, Solomon N, Mac Grory B, Alhanti B, et al
    Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064053.
    PubMed     Abstract available
    
    
    
17. GALPER BZ, Chinnakondepalli KM, Wang K, Magnuson EA, et al
    Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
    Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.062481.
    PubMed     Abstract available
    
    
    
18. PIAZZA G, Spyropoulos AC, Hsia J, Goldin M, et al
    Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
    Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.123.063901.
    PubMed     Abstract available
    
    
    
19. WANG Y, Wang J, Shi L, Chen X, et al
    CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
    Circulation. 2023 May 2. doi: 10.1161/CIRCULATIONAHA.122.062660.
    PubMed     Abstract available
    
    
    April 2023
20. DE BAKKER M, Anand A, Shipley M, Fujisawa T, et al
    Sex Differences in Cardiac Troponin Trajectories Over the Life Course.
    Circulation. 2023 Apr 28. doi: 10.1161/CIRCULATIONAHA.123.064386.
    PubMed     Abstract available
    
    
    
21. 
    Correction to: Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.
    Circulation. 2023;147:e716.
    PubMed    
    
    
    
22. BUTLER J, Talha KM, Fonarow GC
    STRONG-HF and Implementing Heart Failure Therapies: Godspeed ... With Care.
    Circulation. 2023;147:1189-1191.
    PubMed    
    
    
    
23. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    PubMed     Abstract available
    
    
    
24. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    PubMed     Abstract available
    
    
    
25. ALBERT MA
    Economic Adversity and Health Care: Synopsis of American Heart Association Presidential Address.
    Circulation. 2023;147:1115-1117.
    PubMed    
    
    
    March 2023
26. SIPILA PN, Lindbohm JV, David Batty G, Heikkila N, et al
    Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study.
    Circulation. 2023 Mar 27. doi: 10.1161/CIRCULATIONAHA.122.061183.
    PubMed     Abstract available
    
    
    
27. GRECO A, Laudani C, Spagnolo M, Agnello F, et al
    Pharmacology and Clinical Development of Factor XI Inhibitors.
    Circulation. 2023;147:897-913.
    PubMed     Abstract available
    
    
    
28. ASIF KS, Otite FO, Desai SM, Herial N, et al
    Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.
    Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063366.
    PubMed     Abstract available
    
    
    
29. CAMPBELL DJT, Mitchell C, Hemmelgarn BR, Tonelli M, et al
    Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064188.
    PubMed     Abstract available
    
    
    
30. SECEMSKY EA, Song Y, Sun T, Johnson CG, et al
    Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study.
    Circulation. 2023 Mar 3. doi: 10.1161/CIRCULATIONAHA.122.062123.
    PubMed     Abstract available
    
    
    February 2023
31. MILLING TJ JR, Middeldorp S, Xu L, Koch B, et al
    Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
    Circulation. 2023 Feb 20. doi: 10.1161/CIRCULATIONAHA.121.057844.
    PubMed     Abstract available
    
    
    
32. GERSTEIN HC, Li Z, Ramasundarahettige C, Baek S, et al
    Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.
    Circulation. 2023 Feb 20. doi: 10.1161/CIRCULATIONAHA.122.063716.
    PubMed     Abstract available
    
    
    
33. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Circulation. 2023;147:586-596.
    PubMed     Abstract available
    
    
    
34. GABA P, O'Donoghue ML, Park JG, Wiviott SD, et al
    Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
    Circulation. 2023 Feb 13. doi: 10.1161/CIRCULATIONAHA.122.063399.
    PubMed     Abstract available
    
    
    
35. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
    PubMed     Abstract available
    
    
    
36. GRASHOW R, Tan CO, Izzy S, Taylor HA Jr, et al
    Association Between Concussion Burden During Professional American-style Football and Post-career Hypertension.
    Circulation. 2023 Feb 7. doi: 10.1161/CIRCULATIONAHA.122.063767.
    PubMed    
    
    
    
37. CAPONE F, Vettor R, Schiattarella GG
    Cardiometabolic HFpEF: NASH of the Heart.
    Circulation. 2023;147:451-453.
    PubMed    
    
    
    January 2023
38. TSAO CW, Aday AW, Almarzooq ZI, Anderson CAM, et al
    Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
    Circulation. 2023 Jan 25. doi: 10.1161/CIR.0000000000001123.
    PubMed     Abstract available
    
    
    
39. AVITZUR O
    Ralph L. Sacco, 65, Dies: Stroke Expert With a Talent for Architectural Design.
    Circulation. 2023 Jan 17. doi: 10.1161/CIR.0000000000001127.
    PubMed    
    
    
    
40. CAPODANNO D, Angiolillo DJ
    Long-Term P2Y(12) Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.
    Circulation. 2023;147:118-121.
    PubMed    
    
    
    
41. MORTENSEN MB, Dzaye O, Botker HE, Jensen JM, et al
    Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.
    Circulation. 2023 Jan 9. doi: 10.1161/CIRCULATIONAHA.122.061010.
    PubMed     Abstract available
    
    
    
42. NTSEKHE M, Baker JV
    Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
    Circulation. 2023;147:83-100.
    PubMed     Abstract available
    
    
    December 2022
43. WEITZ JI, Eikelboom JW
    What Is the Future of Factor XI Inhibitors?
    Circulation. 2022;146:1899-1902.
    PubMed    
    
    
    
44. PALUCH AE, Bajpai S, Ballin M, Bassett DR, et al
    Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis.
    Circulation. 2022 Dec 20. doi: 10.1161/CIRCULATIONAHA.122.061288.
    PubMed     Abstract available
    
    
    
45. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    PubMed     Abstract available
    
    
    
46. SARMA S, MacNamara JP, Balmain BN, Hearo CM Jr, et al
    Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061828.
    PubMed     Abstract available
    
    
    
47. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
    Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
    PubMed     Abstract available
    
    
    
48. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
    Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
    PubMed     Abstract available
    
    
    
49. MARX N, Husain M, Lehrke M, Verma S, et al
    GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.
    Circulation. 2022;146:1882-1894.
    PubMed     Abstract available
    
    
    
50. ALAHMAD B, Khraishah H, Roye D, Vicedo-Cabrera AM, et al
    Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries.
    Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.122.061832.
    PubMed     Abstract available
    
    
    
51. BENZ AP, Eikelboom JW
    Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
    Circulation. 2022;146:1746-1748.
    PubMed    
    
    
    November 2022
52. TAKAHASHI EA, Schwamm LH, Adeoye OM, Alabi O, et al
    An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Nov 14. doi: 10.1161/CIR.0000000000001107.
    PubMed     Abstract available
    
    
    
53. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    PubMed     Abstract available
    
    
    
54. 
    Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.
    PubMed    
    
    
    
55. KANG J, Park KW, Lee H, Hwang D, et al
    Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
    Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062770.
    PubMed     Abstract available
    
    
    
56. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    PubMed     Abstract available
    
    
    
57. WU H, Xu L, Zhao X, Zhang H, et al
    Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
    PubMed     Abstract available
    
    
    
58. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
    Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
    PubMed     Abstract available
    
    
    October 2022
59. GAZIANO L, Sun L, Arnold M, Bell S, et al
    Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
    PubMed     Abstract available
    
    
    September 2022
60. LEVINE GN, McEvoy JW, Fang JC, Ibeh C, et al
    Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Sep 15:101161CIR0000000000001092.
    PubMed     Abstract available
    
    
    
61. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    PubMed     Abstract available
    
    
    August 2022
62. BOHULA EA, Berg DD, Lopes MS, Connors JM, et al
    Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061533.
    PubMed     Abstract available
    
    
    
63. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
    Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
    PubMed     Abstract available
    
    
    
64. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
    Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
    PubMed     Abstract available
    
    
    
65. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
    State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 18:101161CIR0000000000001089.
    PubMed     Abstract available
    
    
    
66. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    PubMed     Abstract available
    
    
    July 2022
67. KUEHN BM
    Nurse Navigators Cut Stroke Readmissions by Half.
    Circulation. 2022;146:140-141.
    PubMed    
    
    
    
68. HANKEY GJ
    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.
    PubMed    
    
    
    June 2022
69. HAGSTROM E, Steg PG, Szarek M, Bhatt DL, et al
    Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
    Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807.
    PubMed     Abstract available
    
    
    
70. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    PubMed     Abstract available
    
    
    
71. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available
    
    
    April 2022
72. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    PubMed    
    
    
    
73. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    PubMed    
    
    
    
74. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    PubMed    
    
    
    
75. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available
    
    
    
76. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed     Abstract available
    
    
    
77. SPYROPOULOS AC, Raskob GE, Cohen AT, Ageno W, et al
    Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
    Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847.
    PubMed     Abstract available
    
    
    March 2022
78. BORLAUG BA, Blair J, Bergmann MW, Bugger H, et al
    Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Circulation. 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.
    PubMed     Abstract available
    
    
    
79. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available
    
    
    
80. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available
    
    
    
81. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    PubMed    
    
    
    
82. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    PubMed     Abstract available
    
    
    February 2022
83. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    PubMed     Abstract available
    
    
    January 2022
84. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    PubMed     Abstract available
    
    
    
85. AGUADO BA, Walker CJ, Grim JC, Schroeder ME, et al
    Genes that Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
    Circulation. 2022 Jan 10. doi: 10.1161/CIRCULATIONAHA.121.054108.
    PubMed     Abstract available
    
    
    December 2021
86. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    PubMed     Abstract available
    
    
    
87. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.
    PubMed    
    
    
    
88. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.
    PubMed    
    
    
    November 2021
89. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    PubMed    
    
    
    
90. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    PubMed    
    
    
    October 2021
91. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available
    
    
    
92. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    PubMed     Abstract available
    
    
    
93. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    PubMed     Abstract available
    
    
    
94. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available
    
    
    
95. HESS CN, Debus ES, Nehler MR, Anand SS, et al
    Reduction in Acute Limb Ischemia with Rivaroxaban versus Placebo in Peripheral Artery Disease after Lower Extremity Revascularization: Insights from VOYAGER PAD.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.055146.
    PubMed     Abstract available
    
    
    September 2021
96. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    PubMed     Abstract available
    
    
    August 2021
97. LAKKIREDDY D, Thaler D, Ellis CR, Swarup V, et al
    AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER VERSUS WATCHMAN DEVICE FOR STROKE PROPHYLAXIS (AMULET IDE): A RANDOMIZED CONTROLLED TRIAL.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057063.
    PubMed     Abstract available
    
    
    
98. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.
    PubMed    
    
    
    
99. DEBUS ES, Nehler MR, Govsyeyev N, Bauersachs RM, et al
    Effect of Rivaroxaban and Aspirin in Patients with Peripheral Artery Disease Undergoing Surgical Revascularization: Insights from the VOYAGER PAD Trial.
    Circulation. 2021 Aug 12. doi: 10.1161/CIRCULATIONAHA.121.054835.
    PubMed     Abstract available
    
    
    July 2021
100. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
     Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
     Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
     PubMed     Abstract available
     
     
     May 2021
101. CRUMP C, Sundquist J, Sundquist K
     Preterm Delivery and Long-Term Risk of Stroke in Women: A National Cohort and Cosibling Study.
     Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052268.
     PubMed    
     
     
     April 2021
102. TRIFAN G, Gorelick PB, Testai FD
     Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
     Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.121.053782.
     PubMed     Abstract available
     
     
     
103. BENESCH C, Glance LG, Derdeyn CP, Fleisher LA, et al
     Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.
     Circulation. 2021 Apr 8:CIR0000000000000968. doi: 10.1161/CIR.0000000000000968.
     PubMed     Abstract available
     
     
     
104. KAR S, Doshi SK, Sadhu A, Horton R, et al
     Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: Results from the PINNACLE FLX Trial.
     Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.050117.
     PubMed     Abstract available
     
     
     
105. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
     Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
     Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
     PubMed    
     
     
     March 2021
106. SALEH C
     Letter by Saleh Regarding Article, "Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin".
     Circulation. 2021;143:e790-e791.
     PubMed    
     
     
     February 2021
107. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
     Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
     Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
     PubMed     Abstract available
     
     
     
108. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
     Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
     Circulation. 2021;143:837-851.
     PubMed     Abstract available
     
     
     
109. ELGENDY IY, Bukhari S, Barakat AF, Pepine CJ, et al
     Maternal Stroke: A Call for Action.
     Circulation. 2021;143:727-738.
     PubMed     Abstract available
     
     
     
110. RAGHUNATH S, Pfeifer JM, Ulloa-Cerna AE, Nemani A, et al
     Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead Electrocardiogram and Help Identify Those at Risk of AF-Related Stroke.
     Circulation. 2021 Feb 16. doi: 10.1161/CIRCULATIONAHA.120.047829.
     PubMed    
     
     
     January 2021
111. VIRANI SS, Alonso A, Aparicio HJ, Benjamin EJ, et al
     Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
     Circulation. 2021 Jan 27:CIR0000000000000950. doi: 10.1161/CIR.0000000000000950.
     PubMed     Abstract available
     
     
     
112. BENJAMIN EJ, Go AS, Desvigne-Nickens P, Anderson CD, et al
     Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
     Circulation. 2021;143:372-388.
     PubMed     Abstract available
     
     
     
113. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
     Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
     Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
     PubMed     Abstract available
     
     
     
114. LI W, Kessinger CW, Orii M, Lee H, et al
     Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
     Circulation. 2021 Jan 15. doi: 10.1161/CIRCULATIONAHA.120.049096.
     PubMed     Abstract available
     
     
     
115. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
     Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
     Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
     PubMed     Abstract available
     
     
     December 2020
116. KATSANOS AH, Kamel H, Healey JS, Hart RG, et al
     Stroke Prevention in Atrial Fibrillation: Looking Forward.
     Circulation. 2020;142:2371-2388.
     PubMed     Abstract available
     
     
     
117. CHURCHWELL K, Elkind MSV, Benjamin RM, Carson AP, et al
     Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association.
     Circulation. 2020;142:e454-e468.
     PubMed     Abstract available
     
     
     
118. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
     Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
     Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
     PubMed     Abstract available
     
     
     
119. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
     Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
     Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
     PubMed     Abstract available
     
     
     November 2020
120. MARSTON NA, Patel PN, Kamanu FK, Nordio F, et al
     Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease.
     Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051927.
     PubMed     Abstract available
     
     
     October 2020
121. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
     Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
     Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
     PubMed     Abstract available
     
     
     
122. LOWENSTEIN CJ, Solomon SD
     Severe COVID-19 Is a Microvascular Disease.
     Circulation. 2020;142:1609-1611.
     PubMed    
     
     
     
123. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
     Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
     Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
     PubMed    
     
     
     
124. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
     Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
     Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
     PubMed     Abstract available
     
     
     
125. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
     Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
     Circulation. 2020;142:1320-1329.
     PubMed     Abstract available
     
     
     
126. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
     Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
     Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
     PubMed     Abstract available
     
     
     August 2020
127. GAUDINO M, Benesch C, Bakaeen F, DeAnda A, et al
     Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
     Circulation. 2020 Aug 26:CIR0000000000000885. doi: 10.1161/CIR.0000000000000885.
     PubMed     Abstract available
     
     
     July 2020
128. LIBERALE L, Bonetti NR, Puspitasari YM, Schwarz L, et al
     Postischemic Administration of IL-1alpha Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke.
     Circulation. 2020;142:187-189.
     PubMed    
     
     
     June 2020
129. WILLEIT P, Tschiderer L, Allara E, Reuber K, et al
     Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients.
     Circulation. 2020 Jun 17. doi: 10.1161/CIRCULATIONAHA.120.046361.
     PubMed     Abstract available
     
     
     
130. LEE H, Yano Y, Cho SMJ, Park JH, et al
     Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
     Circulation. 2020;141:1778-1786.
     PubMed     Abstract available
     
     
     May 2020
131. YANG L, Han B, Zhang Z, Wang S, et al
     Extracellular Vesicle-Mediated Delivery of CircSCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models.
     Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.120.045765.
     PubMed     Abstract available
     
     
     
132. POTHINENI NVK, Deo R
     Screening for Atrial Fibrillation: Closing the "LOOP".
     Circulation. 2020;141:1523-1526.
     PubMed    
     
     
     April 2020
133. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
     Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
     Circulation. 2020;141:1360-1370.
     PubMed     Abstract available
     
     
     
134. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
     Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
     PubMed     Abstract available
     
     
     March 2020
135. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
     The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
     Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
     PubMed     Abstract available
     
     
     
136. KAPLAN RM, Ziegler PD, Passman RS
     Response by Kaplan et al to Letter Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
     Circulation. 2020;141:e599-e600.
     PubMed    
     
     
     
137. CAO S, Zhu X, Xia M
     Letter by Cao et al Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
     Circulation. 2020;141:e597-e598.
     PubMed    
     
     
     February 2020
138. HARRINGTON RA, Califf RM, Balamurugan A, Brown N, et al
     Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association.
     Circulation. 2020 Feb 10:CIR0000000000000753. doi: 10.1161/CIR.0000000000000753.
     PubMed     Abstract available
     
     
     January 2020
139. VIRANI SS, Alonso A, Benjamin EJ, Bittencourt MS, et al
     Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
     Circulation. 2020 Jan 29:CIR0000000000000757. doi: 10.1161/CIR.0000000000000757.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.